Zhang Junyan, Lei Yuting, Liu Ran, Zhao Hongsen, Li Yuxiao, Zhou Minggang, Li Chen, Rao Li, Jiang Dapeng, Chen Zhongxiu, He Yong
Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Integrated Care Management Center, West China Hospital, Sichuan University, Chengdu, China.
Int J Surg. 2025 Sep 1;111(9):6082-6092. doi: 10.1097/JS9.0000000000002744. Epub 2025 Jun 23.
Patients classified as having a high bleeding risk (HBR) and undergoing percutaneous coronary intervention (PCI) face a significantly greater incidence of net adverse clinical events (NACEs) than non-HBR patients do. Existing risk assessment models, such as the CRUSADE and TIMI scores, do not adequately address the unique risks faced by the HBR population. There is an urgent need for a precise and comprehensive predictive model tailored to PCI-HBR patients to guide clinical decision-making and improve patient outcomes.
This study aimed to develop a machine learning-based predictive model for long-term NACE in PCI-HBR patients. We utilized data from the Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients with Percutaneous Coronary Intervention and High Bleeding Risk registry database. Feature selection and interpretation were performed via a SHapley Additive exPlanations (SHAP) model based on recursive feature elimination. Model construction and evaluation were conducted via four algorithms: logistic regression, random forest, gradient boosting, and XGBoost.
A total of 1512 PCI-HBR patients were included in the study. The XGBoost model demonstrated the highest predictive performance, achieving an area under the receiver operating characteristic curve of 0.85. The SHAP model identified 24 significant variables contributing to the prediction of NACE, including clinical parameters, laboratory findings, and echocardiographic data.
Our machine learning-based model offers a promising tool for predicting long-term NACE in PCI-HBR patients. The model's high predictive accuracy and interpretability have the potential to enhance clinical decision-making and improve patient care. Further validation in larger, diverse populations is warranted to confirm these findings.
被归类为高出血风险(HBR)且接受经皮冠状动脉介入治疗(PCI)的患者发生净不良临床事件(NACE)的发生率明显高于非HBR患者。现有的风险评估模型,如CRUSADE和TIMI评分,并未充分解决HBR人群面临的独特风险。迫切需要一种针对PCI-HBR患者的精确且全面的预测模型,以指导临床决策并改善患者预后。
本研究旨在开发一种基于机器学习的PCI-HBR患者长期NACE预测模型。我们利用了经皮冠状动脉介入治疗和高出血风险患者的预后分析及适当抗血小板策略登记数据库中的数据。通过基于递归特征消除的SHapley加性解释(SHAP)模型进行特征选择和解释。通过逻辑回归、随机森林、梯度提升和XGBoost四种算法进行模型构建和评估。
本研究共纳入1512例PCI-HBR患者。XGBoost模型表现出最高的预测性能,受试者操作特征曲线下面积达到0.85。SHAP模型确定了24个对NACE预测有显著贡献的变量,包括临床参数、实验室检查结果和超声心动图数据。
我们基于机器学习的模型为预测PCI-HBR患者的长期NACE提供了一个有前景的工具。该模型的高预测准确性和可解释性有可能加强临床决策并改善患者护理。有必要在更大、更多样化的人群中进行进一步验证以证实这些发现。